Literature DB >> 18514055

Upregulation of decorin by FXR in vascular smooth muscle cells.

Fengtian He1, Qiuhong Zhang, Ramalinga Kuruba, Xiang Gao, Jiang Li, Yong Li, Wei Gong, Yu Jiang, Wen Xie, Song Li.   

Abstract

Decorin is a member of the family of small leucine-rich proteoglycans that are present in blood vessels and synthesized by vascular smooth muscle cells (VSMCs). Decorin plays complex roles in both normal vascular physiology and the pathogenesis of various types of vascular disorders. However, the mechanisms of regulation of decorin expression in vasculature are not clearly understood. Particularly little information is available about a role of nuclear receptors in the regulation of decorin expression. In the present study, we report that activation of vascular FXR by a specific ligand resulted in upregulation of decorin at the levels of both mRNA and protein. FXR appears to induce decorin expression at a transcriptional level because (1) upregulation of decorin mRNA expression was abolished by the treatment of a transcription inhibitor, actinomycin D; and (2) decorin promoter activity was significantly increased by activation of FXR. Functional analysis of human decorin promoter identified an imperfect inverted repeat DNA motif, IR8 (-2313TGGTCAtagtgtcaTGACCT-2294), as a likely FXR-responsive element that is involved in decorin regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514055      PMCID: PMC2526039          DOI: 10.1016/j.bbrc.2008.05.098

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

1.  NUBIScan, an in silico approach for prediction of nuclear receptor response elements.

Authors:  Michael Podvinec; Michel R Kaufmann; Christoph Handschin; Urs A Meyer
Journal:  Mol Endocrinol       Date:  2002-06

2.  Identification of a chemical tool for the orphan nuclear receptor FXR.

Authors:  P R Maloney; D J Parks; C D Haffner; A M Fivush; G Chandra; K D Plunket; K L Creech; L B Moore; J G Wilson; M C Lewis; S A Jones; T M Willson
Journal:  J Med Chem       Date:  2000-08-10       Impact factor: 7.446

3.  Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung.

Authors:  M Kolb; P J Margetts; P J Sime; J Gauldie
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-06       Impact factor: 5.464

Review 4.  Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans.

Authors:  Paul A McEwan; Paul G Scott; Paul N Bishop; Jordi Bella
Journal:  J Struct Biol       Date:  2006-05-19       Impact factor: 2.867

5.  An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids.

Authors:  W Xie; A Radominska-Pandya; Y Shi; C M Simon; M C Nelson; E S Ong; D J Waxman; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

6.  Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice.

Authors:  Elyisha A Hanniman; Gilles Lambert; Tanya C McCarthy; Christopher J Sinal
Journal:  J Lipid Res       Date:  2005-09-26       Impact factor: 5.922

7.  Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin.

Authors:  M Kolb; P J Margetts; T Galt; P J Sime; Z Xing; M Schmidt; J Gauldie
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

8.  Regulation of proteoglycan synthesis by leukotriene d4 and epidermal growth factor in bronchial smooth muscle cells.

Authors:  Susan Potter-Perigo; Coralie Baker; Christina Tsoi; Kathleen R Braun; Scott Isenhath; Gaylene M Altman; Leonard C Altman; Thomas N Wight
Journal:  Am J Respir Cell Mol Biol       Date:  2003-07-10       Impact factor: 6.914

9.  Control of proliferation, migration, and invasiveness of human extravillous trophoblast by decorin, a decidual product.

Authors:  Guoxiong Xu; Marie-Josée Guimond; Chandan Chakraborty; Peeyush K Lala
Journal:  Biol Reprod       Date:  2002-08       Impact factor: 4.285

10.  A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification.

Authors:  Simrat P S Saini; Junichiro Sonoda; Li Xu; David Toma; Hirdesh Uppal; Ying Mu; Songrong Ren; David D Moore; Ronald M Evans; Wen Xie
Journal:  Mol Pharmacol       Date:  2004-02       Impact factor: 4.436

View more
  2 in total

1.  Vascular accumulation of the small leucine-rich proteoglycan decorin in CADASIL.

Authors:  Soo Jung Lee; Xiaojie Zhang; Michael M Wang
Journal:  Neuroreport       Date:  2014-09-10       Impact factor: 1.837

Review 2.  FXR an emerging therapeutic target for the treatment of atherosclerosis.

Authors:  Andrea Mencarelli; Stefano Fiorucci
Journal:  J Cell Mol Med       Date:  2010-01       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.